These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9305741)
1. Purification and characterization of PAMP-12 (PAMP[9-20]) in porcine adrenal medulla as a major endogenous biologically active peptide. Kuwasako K; Kitamura K; Ishiyama Y; Washimine H; Kato J; Kangawa K; Eto T FEBS Lett; 1997 Sep; 414(1):105-10. PubMed ID: 9305741 [TBL] [Abstract][Full Text] [Related]
2. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). Kitamura K; Kangawa K; Ishiyama Y; Washimine H; Ichiki Y; Kawamoto M; Minamino N; Matsuo H; Eto T FEBS Lett; 1994 Aug; 351(1):35-7. PubMed ID: 8076689 [TBL] [Abstract][Full Text] [Related]
3. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284 [TBL] [Abstract][Full Text] [Related]
4. Distribution and molecular forms of adrenomedullin and proadrenomedullin N-terminal 20 peptide in the porcine gastrointestinal tract. Kiyomizu A; Kitamura K; Kawamoto M; Eto T J Gastroenterol; 2001 Jan; 36(1):18-23. PubMed ID: 11211206 [TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin (11-26): a novel endogenous hypertensive peptide isolated from bovine adrenal medulla. Kitamura K; Matsui E; Kato J; Katoh F; Kita T; Tsuji T; Kangawa K; Eto T Peptides; 2001 Nov; 22(11):1713-8. PubMed ID: 11754956 [TBL] [Abstract][Full Text] [Related]
6. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Inatsu H; Sakata J; Shimokubo T; Kitani M; Nishizono M; Washimine H; Kitamura K; Kangawa K; Matsuo H; Eto T Biochem Mol Biol Int; 1996 Feb; 38(2):365-72. PubMed ID: 8850532 [TBL] [Abstract][Full Text] [Related]
7. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension. Kuwasako K; Kitamura K; Kangawa K; Ishiyama Y; Kato J; Eto T Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():622-8. PubMed ID: 10505213 [TBL] [Abstract][Full Text] [Related]
9. [Adrenomedullin and PAMP]. Kitamura K; Eto T Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408 [TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Marutsuka K; Nawa Y; Asada Y; Hara S; Kitamura K; Eto T; Sumiyoshi A Exp Physiol; 2001 Sep; 86(5):543-5. PubMed ID: 11571480 [TBL] [Abstract][Full Text] [Related]
11. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Etoh T; Kato J; Takenaga M; Imamura T; Kitamura K; Koiwaya Y; Eto T Clin Cardiol; 1999 Feb; 22(2):113-7. PubMed ID: 10068849 [TBL] [Abstract][Full Text] [Related]
13. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930 [TBL] [Abstract][Full Text] [Related]